Andrea L. Hunger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrea L. Hunger has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Jason R. Cantor
Morgridge Institute for Research, Madison, WI 53715, USA
2 shared publications - Carlos A. Mellado Fritz
Morgridge Institute for Research, Madison, USA
1 shared publication - Kelli M. Wilson
Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD 20850, USA
1 shared publication - Kyle M. Flickinger
Morgridge Institute for Research, Madison, USA
1 shared publication - Matthew D. Hall
National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA
1 shared publication - Nicholas J. Rossiter
Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan
1 shared publication
Latest Publications
- Open Access
- 4 October 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (40)
Conditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactions
Chemical screens across hundreds of cell lines have shown that the drug sensitivities of human cancers can vary by genotype or lineage. However, most drug discovery studies have relied on culture media that poorly reflect metabolite levels in human blood. Here, we perform drug screens in traditional and Human Plasma–Like Medium (HPLM). Sets of compounds that show conditional anticancer activity span different phases of global development and include non-oncology drugs. Comparisons of the synthetic and serum-derived components that comprise typical media trace sets of conditional phenotypes to nucleotide synthesis substrates. We also characterize a unique dual mechanism for brivudine, a compound approved for antiviral use. Brivudine selectively impairs cell growth in low folate conditions by targeting two enzymes involved in one-carbon metabolism. Cataloged gene essentiality data further suggest that conditional phenotypes for other compounds are linked to off-target effects. Our findings establish general strategies for identifying drug-nutrient interactions and mechanisms of action by exploiting conditional lethality in cancer cells.
- 4 October 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (40)
Open AccessConditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactions
Chemical screens across hundreds of cell lines have shown that the drug sensitivities of human cancers can vary by genotype or lineage. However, most drug discovery studies have relied on culture media that poorly reflect metabolite levels in human blood. Here, we perform drug screens in traditional and Human Plasma–Like Medium (HPLM). Sets of compounds that show conditional anticancer activity span different phases of global development and include non-oncology drugs. Comparisons of the synthetic and serum-derived components that comprise typical media trace sets of conditional phenotypes to nucleotide synthesis substrates. We also characterize a unique dual mechanism for brivudine, a compound approved for antiviral use. Brivudine selectively impairs cell growth in low folate conditions by targeting two enzymes involved in one-carbon metabolism. Cataloged gene essentiality data further suggest that conditional phenotypes for other compounds are linked to off-target effects. Our findings establish general strategies for identifying drug-nutrient interactions and mechanisms of action by exploiting conditional lethality in cancer cells.
- Open Access
- 13 April 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , S460
Abstract 1306: Investigating the Conditionally Essential Role of BCL2L1 in Human Cells
- 13 April 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (3) , S460
Open AccessAbstract 1306: Investigating the Conditionally Essential Role of BCL2L1 in Human Cells